Replimune (REPL) Amortizatization of Intangibles (2024 - 2025)

Replimune's (REPL) quarterly Amortizatization of Intangibles came in at $607000.0 in Q4 2025, little changed year-on-year from $607000.0 in Q4 2024, and little changed quarter-over-quarter from $607000.0 in Q3 2025.

Replimune (REPL) Amortizatization of Intangibles (2024 - 2025) Analysis & Trends

Replimune has disclosed Amortizatization of Intangibles across 2 years of filings, most recently posting $607000.0 for Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - 13,267.00
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn -
9 Abivax 91.71 Bn 91.71 Bn - -
10 Replimune 780.01 Mn 510.88 Mn - 607,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 607,000.00
Dec 31, 2025 607,000.00
Sep 30, 2025 607,000.00
Sep 30, 2025 607,000.00
Jun 30, 2025 607,000.00
Jun 30, 2025 607,000.00
Dec 31, 2024 607,000.00
Dec 31, 2024 607,000.00
Sep 30, 2024 607,000.00
Sep 30, 2024 607,000.00
Jun 30, 2024 164,000.00
Jun 30, 2024 164,000.00